drugset / Trial / NCT03868098

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

NCT03868098

Phase 4 Completed 31 enrolled Innovaderm Research Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is being conducted to evaluate the efficacy and safety of 3 different application rates of topically applied Crisaborole ointment 2% over vehicle in adults with mild to moderate atopic dermatitis (AD). In each subject four application areas will be identified. Each subject will receive 4 treatments: the 3 different application rates of the active treatment and the vehicle. The areas will be randomly assigned to treatment with topical Crisaborole ointment 2% and vehicle, once daily, for 2 weeks, without occlusion.

Timeline

Start
2019-05-21
Primary completion
2020-11-25
Completion
2020-11-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Crisaborole Small molecule 2 % Topical

Indications